Collectively, our findings suggested a potential protective role for Ism1 against obesity and its complications, indicating it as a potential biomarker or diagnostic tool for early detection of metabolic diseases, warranting further investigation into its therapeutic potential. This evidence concerns the gene ISM1 and obesity due to melanocortin 4 receptor deficiency.